Rompag 50 mg Tablet (Eltrombopag): Uses, Benefits, Side Effects, Dosage & Safety

Rompag 50 mg Tablet contains eltrombopag 50 mg, a medicine belonging to the class of thrombopoietin receptor agonists. It is used under medical supervision to help increase platelet production in certain conditions associated with low platelet counts and, in appropriate patients, to support treatment of severe aplastic anemia.

The product shown in the provided pack is Rompag 50 mg, with a pack size marked 4 × 7 tablets. Available Indian medicine references identify Rompag 50 mg as being marketed by Hetero Healthcare Pvt. Ltd.

Because eltrombopag can affect platelet levels and liver function, treatment generally requires medical monitoring and laboratory testing. It should not be started, stopped, or adjusted without advice from a qualified healthcare professional.

1. What is Rompag 50 mg?

Rompag 50 mg is an oral prescription medicine containing eltrombopag as its active ingredient. Eltrombopag is a thrombopoietin receptor agonist, meaning it works on the body’s platelet-producing system.

Platelets are blood cells that help the body form clots and control bleeding. When platelet levels become too low, a person may have an increased risk of bleeding. Eltrombopag stimulates thrombopoietin receptors on blood-forming cells in the bone marrow, encouraging the production of more platelets.

Doctors may prescribe eltrombopag-containing medicines for conditions such as:

• Chronic immune thrombocytopenia (ITP) in appropriate patients
• Thrombocytopenia associated with chronic hepatitis C in appropriate treatment settings
• Severe aplastic anemia in selected patients

The exact indication depends on the patient’s condition, medical history, previous treatment and local prescribing recommendations.

Rompag 50 mg should only be used according to a doctor’s prescription because the appropriate dose and duration can vary considerably between patients.

2. Uses of Rompag 50 mg

Rompag 50 mg uses are mainly related to conditions in which platelet production needs to be increased.

Common medically accepted uses include:

• Management of chronic immune thrombocytopenia (ITP): It may be prescribed when other treatments have not provided an adequate response.
• Treatment of thrombocytopenia associated with chronic hepatitis C: In selected patients, eltrombopag may be used when increasing platelet counts is clinically necessary.
• Treatment of severe aplastic anemia: It may be used in appropriate patients to stimulate blood-cell production.
• Support of platelet production: The medicine helps the bone marrow produce more platelets through stimulation of thrombopoietin receptors.

Rompag 50 mg is not a general treatment for every cause of low platelet count. A doctor must determine the underlying cause before considering treatment.

This medicine should only be taken under the supervision of a qualified healthcare professional.

3. Benefits of Rompag 50 mg

The potential Rompag 50 mg benefits come from its ability to stimulate platelet production.

Potential benefits include:

• Helps increase platelet production in appropriate patients
• Helps manage low platelet counts associated with certain medical conditions
• May reduce the risk associated with very low platelet levels when effective
• Can support ongoing management of chronic immune thrombocytopenia
• May be used as part of treatment for severe aplastic anemia in selected patients

Rompag 50 mg does not guarantee normalization of platelet counts and does not cure the underlying condition in every patient. Doctors generally monitor platelet levels and adjust treatment according to the patient’s response.

4. How Does Rompag 50 mg Work?

The active ingredient eltrombopag works by stimulating the thrombopoietin (TPO) receptor.

Thrombopoietin is an important natural signal involved in platelet production. Eltrombopag activates the TPO receptor on certain blood-forming cells in the bone marrow. This encourages the development of cells involved in platelet production and can subsequently increase the number of circulating platelets.

In simple terms, Rompag 50 mg helps the body’s bone marrow produce more platelets when platelet production needs additional stimulation.

5. How to Take Rompag 50 mg

The Rompag 50 mg dosage must be determined by the treating doctor. Do not change the prescribed dose based on your platelet count or symptoms.

General guidance includes:

• Take Rompag exactly as prescribed.
• It is generally taken once daily when prescribed for conditions requiring eltrombopag.
• Take it on an empty stomach, usually at least 1 hour before or 2 hours after food, unless your healthcare professional gives different instructions.
• Swallow the tablet whole with water.
• Do not crush, chew or split the tablet unless specifically instructed.
• Calcium-rich foods and certain mineral-containing products can interfere with absorption. Eltrombopag should be separated from calcium-containing foods and certain supplements according to medical instructions.
• Do not take an extra dose if you miss one unless your doctor specifically instructs you to do so.

Regular blood tests are important during treatment because the dose may need adjustment according to platelet response and safety laboratory results.

6. Side Effects of Rompag 50 mg

Like all medicines, Rompag 50 mg may cause side effects, although not everyone experiences them.

Common Side Effects

Possible side effects may include:

• Headache
• Nausea
• Diarrhea
• Tiredness
• Muscle aches
• Changes in liver-related blood tests

The specific side effects and their severity can vary between individuals and may also depend on the condition being treated.

Serious Side Effects

Eltrombopag can cause important complications that require medical attention. These may include:

• Liver problems or abnormal liver-function tests
• Blood clots or thromboembolic complications
• Significant changes in blood counts
• Eye-related problems such as cataracts in some patients

Seek prompt medical attention for symptoms that could indicate a serious problem, such as yellowing of the skin or eyes, dark urine, unusual abdominal symptoms, sudden breathing difficulty, chest pain, or swelling and pain in a limb.

If side effects persist or become severe, contact your healthcare provider promptly.

7. Warnings and Precautions

Before taking Rompag 50 mg, tell your doctor if you have:

• Liver disease or abnormal liver-function tests
• A history of blood clots
• Medical conditions that increase the risk of clotting
• A history of cataracts or other eye problems
• A history of spleen removal
• Any known allergy to eltrombopag or its ingredients

Eltrombopag can affect liver function, so doctors may order liver-function tests before and during treatment.

Pregnancy and Breastfeeding

Tell your doctor if you are pregnant, planning pregnancy, or breastfeeding. Eltrombopag may not be appropriate during pregnancy or breastfeeding, and the healthcare professional should assess the potential benefits and risks.

Kidney or Heart Problems

Inform your doctor about kidney disease, heart-related conditions, previous blood clots, or other significant medical problems. These factors may influence treatment decisions and monitoring.

Alcohol and Driving

Discuss alcohol consumption with your healthcare professional, particularly because eltrombopag can affect the liver. If you experience dizziness, tiredness, visual problems, or other symptoms that affect alertness, avoid driving or operating machinery until you know how the medicine affects you.

8. Drug Interactions

Rompag 50 mg may interact with other medicines, supplements and minerals.

Tell your doctor or pharmacist about all products you use, including:

• Prescription medicines
• Over-the-counter medicines
• Antacids
• Calcium, iron, zinc or selenium supplements
• Vitamins and minerals
• Herbal products

Antacids containing calcium, aluminium or magnesium and supplements containing certain minerals can interfere with eltrombopag absorption. These products may need to be taken several hours apart from eltrombopag.

Do not start a new medicine or supplement without checking with your healthcare professional.

9. Storage Instructions

For proper storage of Rompag 50 mg:

• Keep the tablets in their original packaging or container.
• Store at room temperature as directed on the product packaging.
• Protect the medicine from excessive heat and moisture.
• Keep it away from direct sunlight.
• Keep the medicine out of reach of children.
• Do not use the medicine after its expiry date.

Follow the storage instructions supplied with the specific product pack.

10. Rompag 50 mg Price and Manufacturer

The Rompag 50 mg price can vary depending on the pharmacy, location, pack size, discounts, taxes and availability. Therefore, the current selling price should be confirmed with a licensed pharmacy rather than relying on an old online listing.

Indian pharmacy references identify Hetero Healthcare Pvt. Ltd. as the manufacturer/marketer of Rompag 50 mg Tablet.

Patients should verify the product, strength, batch details and expiry date before purchase and use.

11. Disclaimer

This information about Rompag 50 mg medicine is provided for educational purposes only and should not be considered medical advice. It does not replace consultation with a qualified doctor, pharmacist, or other healthcare professional.

Do not self-medicate with eltrombopag or change the prescribed dosage without medical advice. The appropriate treatment plan depends on the patient’s diagnosis, platelet count, liver function, other medicines, and overall health. Individual responses to treatment may vary.

Frequently Asked Questions

1. What is Rompag 50 mg used for?

Rompag 50 mg contains eltrombopag and is used in selected patients to manage low platelet counts associated with conditions such as chronic immune thrombocytopenia, chronic hepatitis C-related thrombocytopenia, and severe aplastic anemia. The exact indication depends on the patient’s medical condition and doctor’s assessment.

2. How does Rompag 50 mg work?

Eltrombopag stimulates thrombopoietin receptors on blood-forming cells in the bone marrow. This encourages platelet production and can increase the number of platelets circulating in the blood. It is therefore classified as a thrombopoietin receptor agonist.

3. Is Rompag 50 mg safe?

Rompag 50 mg can be appropriate when prescribed and monitored by a healthcare professional. However, eltrombopag has important risks, including liver problems and blood-clotting complications. Doctors may perform blood tests and other monitoring during treatment to manage these risks.

4. Can Rompag 50 mg be taken long term?

Some patients may require longer-term treatment, depending on their medical condition and response. Long-term use should remain under medical supervision because platelet counts, liver function and other safety parameters may need regular monitoring. Never continue or stop treatment for an extended period without discussing it with your doctor.

5. What happens if I miss a dose of Rompag 50 mg?

If you miss a dose, follow the instructions provided by your doctor or pharmacist. For eltrombopag, a missed dose is generally not replaced with a double dose. Do not take more than the prescribed amount in one day.

6. Can I stop taking Rompag 50 mg suddenly?

Do not stop Rompag 50 mg without speaking with your doctor. Your platelet count may fall after treatment is discontinued, and monitoring is recommended after stopping eltrombopag. Your doctor will decide whether treatment should continue, change, or stop.

7. Can Rompag 50 mg be taken with food?

Eltrombopag is generally taken on an empty stomach because food can affect its absorption. Calcium-rich foods and certain mineral supplements also require special timing. Follow the exact dietary and timing instructions provided by your healthcare professional.

8. What are the common Rompag 50 mg side effects?

Possible side effects can include headache, nausea, diarrhea, tiredness, muscle-related symptoms and abnormal liver-function tests. Side effects vary from person to person. Report persistent, unusual, or severe symptoms to your healthcare professional.

9. Who should avoid Rompag 50 mg?

Rompag 50 mg should not be used without medical assessment, particularly in people with liver disease, a history of blood clots, certain eye conditions, or allergies to eltrombopag or its ingredients. Your doctor will determine whether the medicine is appropriate for you.

10. How should Rompag 50 mg be stored?

Keep Rompag 50 mg in its original packaging, at the storage conditions specified on the pack, away from excessive heat and moisture. Keep it out of children’s reach and do not use tablets after the expiry date.